Protagonist Therapeutics, Inc. (PTGX) SEC filings
PTGX SEC filings moved a median of +0.63% by the close. PTGX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the PTGX overview →
55 measured PTGX SEC filing events.
Where these PTGX SEC filings landedvs 55 measured PTGX SEC filing reactions
| Middle 50% of PTGX SEC filing reactions | -1.95% to +1.26% |
|---|---|
| Median reaction (to close) | +0.63% |
| Measured reactions | 55 |
Point-in-time · zero look-ahead
Half of the 55 PTGX SEC filing events with a measured close landed between -1.95% and +1.26%; 64% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Protagonist Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -0.72% | +0.81% | |
| Form 8-K Protagonist Therapeutics For: Aug 05 | SEC filing · Form 8-K | -0.72% | +0.81% | |
| Form S-8 Protagonist Therapeutics | SEC filing · Form S-8 | -0.72% | +0.81% | |
| Form S-8 POS Protagonist Therapeutics | SEC filing · Form S-8 | -0.72% | +0.81% | |
| Form 8-K Protagonist Therapeutics For: Jun 17 | SEC filing · Form 8-K | +1.29% | +1.58% | |
| Form 10-Q Protagonist Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -1.51% | +0.94% | |
| Form 8-K Protagonist Therapeutics For: May 05 | SEC filing · Form 8-K | -1.51% | +0.94% | |
| Form ARS Protagonist Therapeutics For: Dec 31 | SEC filing · Form ARS | -0.47% | -1.75% | |
| Form DEF 14A Protagonist Therapeutics For: Jun 17 | SEC filing · Form DEF | -0.47% | -1.75% | |
| Form DEFA14A Protagonist Therapeutics | SEC filing · Form DEFA14A | -0.47% | -1.75% | |
| Form 10-K Protagonist Therapeutics For: Dec 31 | SEC filing · Form 10-K | -0.94% | +1.02% | |
| Form 8-K Protagonist Therapeutics For: Feb 25 | SEC filing · Form 8-K | -0.94% | +1.02% | |
| Form S-8 Protagonist Therapeutics | SEC filing · Form S-8 | -0.94% | +1.02% | |
| Form 8-K Protagonist Therapeutics For: Jan 12 | SEC filing · Form 8-K | -0.26% | +0.96% | |
| Form 10-Q Protagonist Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -2.86% | -0.72% | |
| Form 8-K Protagonist Therapeutics For: Nov 06 | SEC filing · Form 8-K | -2.86% | -0.72% | |
| Form 10-Q Protagonist Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +0.15% | -5.84% | |
| Form 8-K Protagonist Therapeutics For: Aug 06 | SEC filing · Form 8-K | +0.15% | -5.84% | |
| Form S-3ASR Protagonist Therapeutics | SEC filing · Form S-3ASR | +0.15% | -5.84% | |
| Form 8-K Protagonist Therapeutics For: Jun 20 | SEC filing · Form 8-K | -0.48% | +0.63% | |
| Form 10-Q Protagonist Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +0.23% | +3.16% | |
| Form 8-K Protagonist Therapeutics For: May 06 | SEC filing · Form 8-K | +0.23% | +3.16% | |
| Form ARS Protagonist Therapeutics For: Dec 31 | SEC filing · Form ARS | -1.10% | +1.26% | |
| Form DEF 14A Protagonist Therapeutics For: Jun 20 | SEC filing · Form DEF | -1.10% | +1.26% | |
| Form DEFA14A Protagonist Therapeutics | SEC filing · Form DEFA14A | -1.10% | +1.26% | |
| Form 8-K Protagonist Therapeutics For: Mar 17 | SEC filing · Form 8-K | -1.94% | -1.09% | |
| Form 8-K/A Protagonist Therapeutics For: Mar 08 | SEC filing · Form 8-K | +0.56% | -2.55% | |
| Form 8-K Protagonist Therapeutics For: Mar 08 | SEC filing · Form 8-K | +0.84% | +11.72% | |
| Form 8-K Protagonist Therapeutics For: Mar 03 | SEC filing · Form 8-K | +0.98% | -5.66% | |
| Form 10-K Protagonist Therapeutics For: Dec 31 | SEC filing · Form 10-K | -2.12% | -7.10% | |
| Form 8-K Protagonist Therapeutics For: Feb 21 | SEC filing · Form 8-K | -1.01% | -2.15% | |
| Form S-8 Protagonist Therapeutics | SEC filing · Form S-8 | -2.12% | -7.10% | |
| Form 8-K Protagonist Therapeutics For: Jan 01 | SEC filing · Form 8-K | +1.23% | +0.44% | |
| Form 8-K Protagonist Therapeutics For: Nov 13 | SEC filing · Form 8-K | -12.52% | +0.99% | |
| Form 10-Q Protagonist Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -3.56% | -5.38% | |
| Form 8-K Protagonist Therapeutics For: Nov 07 | SEC filing · Form 8-K | -3.56% | -5.38% | |
| Form 8-K Protagonist Therapeutics For: Sep 17 | SEC filing · Form 8-K | +0.79% | -2.31% | |
| Form 10-Q Protagonist Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +1.88% | -2.29% | |
| Form 8-K Protagonist Therapeutics For: Aug 06 | SEC filing · Form 8-K | -1.55% | +2.35% | |
| Form 8-K Protagonist Therapeutics For: Jun 20 | SEC filing · Form 8-K | -0.77% | +0.22% | |
| Form 10-Q Protagonist Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -1.96% | +0.11% | |
| Form 8-K Protagonist Therapeutics For: May 07 | SEC filing · Form 8-K | -1.96% | +0.11% | |
| Form ARS Protagonist Therapeutics For: Dec 31 | SEC filing · Form ARS | -0.59% | +0.51% | |
| Form DEF 14A Protagonist Therapeutics For: Jun 20 | SEC filing · Form DEF | -0.59% | +0.51% | |
| Form DEFA14A Protagonist Therapeutics | SEC filing · Form DEFA14A | -0.59% | +0.51% | |
| Form PRE 14A Protagonist Therapeutics For: Jun 20 | SEC filing · Form PRE | -0.66% | -2.21% | |
| Form 10-K Protagonist Therapeutics For: Dec 31 | SEC filing · Form 10-K | +1.28% | +1.43% | |
| Form 8-K Protagonist Therapeutics For: Feb 27 | SEC filing · Form 8-K | +1.28% | +1.43% | |
| Form S-8 Protagonist Therapeutics | SEC filing · Form S-8 | +1.28% | +1.43% | |
| Form 8-K Protagonist Therapeutics For: Jan 31 | SEC filing · Form 8-K | -1.05% | +7.22% | |
| Form 8-K Protagonist Therapeutics For: Jan 09 | SEC filing · Form 8-K | -1.41% | -3.90% | |
| Form 8-K Protagonist Therapeutics For: Jan 08 | SEC filing · Form 8-K | +0.09% | +5.74% | |
| Form 10-Q Protagonist Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +0.32% | +5.58% | |
| Form 8-K Protagonist Therapeutics For: Nov 02 | SEC filing · Form 8-K | +0.32% | +5.58% | |
| Form 8-K Protagonist Therapeutics For: Oct 26 | SEC filing · Form 8-K | -1.13% | +2.76% |
Keep exploring
More PTGX: earnings → · analyst actions → · PTGX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Cardinal Health, Inc. (CAH) | 335 | +0.02% | 52% |
| MannKind Corporation (MNKD) | 335 | -0.25% | 43% |
| MYOS RENS TECH INC COMMON (MYOS) | 334 | 0.00% | 43% |
| Actelis Networks, Inc. (ASNS) | 331 | -0.83% | 36% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.